Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
Multiple sclerosis: a comprehensive review for the physician assistant.
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.
Age-Dependent Seroprevalence of JCV Antibody in Children.
Immunotherapy of Multiple Sclerosis : The State of the Art.
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
[Clinical validity of the quantitative gait variables in patients with multiple sclerosis. A comparison of the Timed 25-foot Walk Test and the GAITRite ® Electronic Walkway system].
Selective depression of low-release probability excitatory synapses by sodium channel blockers.
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
Diagnosis and treatment of pediatric acute transverse myelitis.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
The role of interleukin-6 signaling in nervous tissue.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Proteomic analysis of the anti-inflammatory action of minocycline.
Pages
« first
‹ previous
…
204
205
206
207
208
209
210
211
212
…
next ›
last »